American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 15% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.1% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Dollar General
DG
$27.1B
| $4.8M | ﹤0.01% |
19,564
+3,850
| +25% | +$899K |
|
|
HIBB
1127
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $4.8M | ﹤0.01% |
109,838
+21,422
| +24% | +$988K |
|
1128
Corteva
CTVA
$51.1B
| $4.78M | ﹤0.01% |
88,309
+20,360
| +30% | +$1.18M |
|
1129
GoPro
GPRO
$111M
| $4.78M | ﹤0.01% |
863,735
+476,944
| +123% | +$3.49M |
|
1130
FIVE9
FIVN
$2.42B
| $4.77M | ﹤0.01% |
+52,319
| New | +$5.29M |
|
|
FFWM
1131
DELISTED
First Foundation Inc
FFWM
| $4.71M | ﹤0.01% |
229,983
+55,841
| +32% | +$1.24M |
|
1132
Jackson Financial
JXN
$9.17B
| $4.64M | ﹤0.01% |
+173,646
| New | +$6.33M |
|
1133
Quanex
NX
$960M
| $4.63M | ﹤0.01% |
203,513
+30,277
| +17% | +$632K |
|
1134
Darden Restaurants
DRI
$25.5B
| $4.62M | ﹤0.01% |
40,813
+17,003
| +71% | +$2.12M |
|
1135
McDonald's
MCD
$194B
| $4.6M | ﹤0.01% |
18,632
+2,978
| +19% | +$733K |
|
1136
Costamare
CMRE
$1.75B
| $4.58M | ﹤0.01% |
378,288
+108,550
| +40% | +$1.51M |
|
1137
DHT Holdings
DHT
$3.15B
| $4.51M | ﹤0.01% |
736,300
+55,938
| +8% | +$329K |
|
1138
Hanmi Financial
HAFC
$968M
| $4.48M | ﹤0.01% |
199,778
+45,912
| +30% | +$1.06M |
|
|
ECHO
1139
EchoStar
ECHO
$26.6B
| $4.48M | ﹤0.01% |
232,244
+42,406
| +22% | +$957K |
|
1140
Enterprise Financial Services Corp
EFSC
$2.41B
| $4.48M | ﹤0.01% |
107,929
+66,533
| +161% | +$2.96M |
|
|
ORAN
1141
DELISTED
Orange
ORAN
| $4.48M | ﹤0.01% |
380,249
+110,820
| +41% | +$1.33M |
|
1142
Kymera Therapeutics
KYMR
$9.52B
| $4.47M | ﹤0.01% |
226,859
+13,899
| +7% | +$325K |
|
1143
Moog Inc Class A
MOG.A
$13.8B
| $4.44M | ﹤0.01% |
55,941
+17,148
| +44% | +$1.39M |
|
1144
Great Southern Bancorp
GSBC
$893M
| $4.43M | ﹤0.01% |
75,668
+17,305
| +30% | +$1.01M |
|
|
CPRX
1145
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.43M | ﹤0.01% |
631,904
+286,556
| +83% | +$2.1M |
|
1146
Park National Corp
PRK
$3.76B
| $4.42M | ﹤0.01% |
36,428
+11,530
| +46% | +$1.39M |
|
1147
Shinhan Financial Group
SHG
$35.6B
| $4.4M | ﹤0.01% |
153,915
+32,485
| +27% | +$1.06M |
|
1148
Mercer International
MERC
$33M
| $4.38M | ﹤0.01% |
332,854
+115,844
| +53% | +$1.71M |
|
|
VSXY
1149
Victoria's Secret
VSXY
$7.13B
| $4.37M | ﹤0.01% |
156,268
+137,475
| +732% | +$5.95M |
|
1150
Synchrony
SYF
$26.2B
| $4.37M | ﹤0.01% |
158,237
+49,773
| +46% | +$1.73M |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.